BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2719362)

  • 1. Use of emergency medical services by patients with decompensated obstructive lung disease.
    Murata GH; Gorby MS; Chick TW; Halperin AK
    Ann Emerg Med; 1989 May; 18(5):501-6. PubMed ID: 2719362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of decompensated chronic obstructive pulmonary disease in the emergency department--correlation between clinical features and prognosis.
    Murata GH; Gorby MS; Chick TW; Halperin AK
    Ann Emerg Med; 1991 Feb; 20(2):125-9. PubMed ID: 1996791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivariate model for predicting hospital admissions for patients with decompensated chronic obstructive pulmonary disease.
    Murata GH; Gorby MS; Kapsner CO; Chick TW; Halperin AK
    Arch Intern Med; 1992 Jan; 152(1):82-6. PubMed ID: 1728933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multivariate model for the prediction of relapse after outpatient treatment of decompensated chronic obstructive pulmonary disease.
    Murata GH; Gorby MS; Kapsner CO; Chick TW; Halperin AK
    Arch Intern Med; 1992 Jan; 152(1):73-7. PubMed ID: 1728932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective, double-blind study of peak flow changes prior to emergency department visits.
    Murata GH; Kapsner CO; Lium DJ; Busby HK
    Respir Med; 1998 Jul; 92(7):936-41. PubMed ID: 10070567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency department return visits in chronic obstructive pulmonary disease: the importance of psychosocial factors.
    Stehr DE; Klein BJ; Murata GH
    Ann Emerg Med; 1991 Oct; 20(10):1113-6. PubMed ID: 1928884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Effect on patients with a history of multiple relapses.
    Murata GH; Gorby MS; Chick TW; Halperin AK
    Chest; 1990 Oct; 98(4):845-9. PubMed ID: 2209140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multivariate model for predicting respiratory status in patients with chronic obstructive pulmonary disease.
    Murata GH; Kapsner CO; Lium DJ; Busby HK
    J Gen Intern Med; 1998 Jul; 13(7):462-8. PubMed ID: 9686712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ACOS: Clinical and functional features The Russian formulation mesalazine (kansalazine) in the therapy of ulcerative colitis].
    Sobko EA; Chubarova SV; Demko IV; Loktionova MM; Ishchenko OP; Solovyeva IA; Kraposhina AY; Gordeeva NV
    Ter Arkh; 2017; 89(12):68-75. PubMed ID: 29411763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.
    Dompeling E; van Schayck CP; van Grunsven PM; van Herwaarden CL; Akkermans R; Molema J; Folgering H; van Weel C
    Ann Intern Med; 1993 May; 118(10):770-8. PubMed ID: 8470851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with relapse after emergency department treatment for acute asthma.
    Emerman CL; Cydulka RK
    Ann Emerg Med; 1995 Jul; 26(1):6-11. PubMed ID: 7793723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.
    Hansen EF; Phanareth K; Laursen LC; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1267-71. PubMed ID: 10194175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminophylline in the outpatient management of decompensated chronic obstructive pulmonary disease.
    Murata GH; Gorby MS; Chick TW; Halperin AK
    Chest; 1990 Dec; 98(6):1346-50. PubMed ID: 2123149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.